China Pharma Holdings Return on Investment 2010-2023 | CPHI
Current and historical return on investment (ROI) values for China Pharma Holdings (CPHI) over the last 10 years.
| China Pharma Holdings ROI - Return on Investment Historical Data |
| Date |
TTM Net Income |
LT Investments & Debt |
Return on Investment |
| 2023-12-31 |
$-0.00B |
$0.01B |
-47.06% |
| 2023-09-30 |
$-0.00B |
$0.01B |
-100.00% |
| 2023-06-30 |
$-0.00B |
|
inf% |
| 2023-03-31 |
$-0.00B |
|
-133.33% |
| 2022-12-31 |
$-0.00B |
|
-84.21% |
| 2022-09-30 |
$-0.00B |
|
-53.33% |
| 2022-06-30 |
$-0.00B |
$0.01B |
-53.33% |
| 2022-03-31 |
$-0.00B |
$0.01B |
-57.14% |
| 2021-12-31 |
$-0.00B |
$0.01B |
-61.54% |
| 2021-09-30 |
$-0.00B |
|
-66.67% |
| 2021-06-30 |
$-0.00B |
$0.01B |
-48.48% |
| 2021-03-31 |
$-0.00B |
$0.01B |
-32.43% |
| 2020-12-31 |
$-0.00B |
$0.01B |
-30.77% |
| 2020-09-30 |
$-0.02B |
$0.01B |
-204.88% |
| 2020-06-30 |
$-0.02B |
$0.01B |
-137.70% |
| 2020-03-31 |
$-0.02B |
$0.01B |
-106.02% |
| 2019-12-31 |
$-0.02B |
$0.01B |
-77.78% |
| 2019-09-30 |
$-0.01B |
$0.03B |
-30.30% |
| 2019-06-30 |
$-0.01B |
$0.03B |
-30.34% |
| 2019-03-31 |
$-0.01B |
$0.04B |
-27.50% |
| 2018-12-31 |
$-0.01B |
$0.04B |
-24.86% |
| 2018-09-30 |
$-0.02B |
$0.04B |
-35.42% |
| 2018-06-30 |
$-0.02B |
$0.05B |
-31.78% |
| 2018-03-31 |
$-0.02B |
$0.05B |
-31.03% |
| 2017-12-31 |
$-0.02B |
$0.05B |
-30.77% |
| 2017-09-30 |
$-0.01B |
$0.06B |
-12.08% |
| 2017-06-30 |
$-0.01B |
$0.07B |
-11.64% |
| 2017-03-31 |
$-0.01B |
$0.07B |
-11.19% |
| 2016-12-31 |
$-0.01B |
$0.07B |
-10.63% |
| 2016-09-30 |
$-0.02B |
$0.07B |
-25.32% |
| 2016-06-30 |
$-0.02B |
$0.08B |
-18.07% |
| 2016-03-31 |
$-0.01B |
$0.08B |
-13.30% |
| 2015-12-31 |
$-0.02B |
$0.08B |
-15.83% |
| 2015-09-30 |
$-0.02B |
$0.09B |
-22.00% |
| 2015-06-30 |
$-0.03B |
$0.11B |
-28.44% |
| 2015-03-31 |
$-0.04B |
$0.10B |
-35.34% |
| 2014-12-31 |
$-0.04B |
$0.10B |
-30.83% |
| 2014-09-30 |
$-0.03B |
$0.13B |
-18.28% |
| 2014-06-30 |
$-0.02B |
$0.13B |
-15.44% |
| 2014-03-31 |
$-0.02B |
$0.14B |
-16.51% |
| 2013-12-31 |
$-0.02B |
$0.15B |
-25.85% |
| 2013-09-30 |
$-0.01B |
$0.15B |
-32.21% |
| 2013-06-30 |
$-0.01B |
|
inf% |
| 2013-03-31 |
$0.00B |
|
nan% |
| 2012-12-31 |
$0.01B |
|
inf% |
| 2012-09-30 |
$0.01B |
|
inf% |
| 2012-06-30 |
$0.02B |
|
inf% |
| 2012-03-31 |
$0.02B |
|
inf% |
| 2011-12-31 |
$0.02B |
|
inf% |
| 2011-09-30 |
$0.03B |
|
inf% |
| 2011-06-30 |
$0.03B |
|
inf% |
| 2011-03-31 |
$0.02B |
|
inf% |
| 2010-12-31 |
$0.02B |
|
inf% |
| 2010-09-30 |
$0.02B |
|
inf% |
| 2010-06-30 |
$0.02B |
|
inf% |
| 2010-03-31 |
$0.02B |
|
inf% |
| 2009-12-31 |
$0.02B |
|
inf% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.005B |
$0.007B |
|
CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.
|
